#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Experience with ciclesonide in patients with mild persistent bronchial asthma


Authors: L. Bartošíková;  J. Nečas;  L. Fráňa 1;  T. Bartošík 2
Authors‘ workplace: Univerzita Palackého, Lékařská fakulta, Ústav fyziologie, Olomouc ;  Dům zdraví, Velké Meziříčí 1;  Anesteziologicko-resuscitační klinika FN U sv. Anny v Brně 2
Published in: Čes. slov. Farm., 2007; 56, 276-279
Category: Original Articles

Overview

The study aimed to monitor the effectiveness and safety of the treatment with ciclesonide, administered once a day in a 160 μg dose, over a 3-month period, to a group of 100 patients diagnosed with mild persistent bronchial asthma with deterioration of problems after exercise. The results of the study prove significant positive effects of the preparation used. A significant improvement of FEV₁ and PEF values was observed, as well as a statistically significant remission of both day and nocturnal symptoms of the disease, a significantly lower consumption of shortacting β₂-sympathomimetics, and an improvement of all evaluated data relating to the quality of life of the asthmatic patients. No adverse effects were registered.

Key words:
ciclesonide – inhaled corticosteroids – bronchial asthma


Labels
Pharmacy Clinical pharmacology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#